Page last updated: 2024-12-10
tauropine
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
tauropine: RN given from CA Index Guide 1985; RN not in Chemline 12/86 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
tauropine : A derivative of L-alanine having a 2-sulfoethyl group attached to the alpha-nitrogen. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 3082376 |
| CHEBI ID | 16461 |
| SCHEMBL ID | 3713939 |
| MeSH ID | M0144294 |
Synonyms (15)
| Synonym |
|---|
| rhodoic acid |
| d-alanine, n-(2-sulfoethyl)- |
| CHEBI:16461 |
| n-(2-sulfoethyl)-d-alanine |
| n-(1-carboxyethyl)taurine |
| n(2)-(d-1-carboxyethyl)-2-aminoethanesulfonate |
| C01616 |
| tauropine |
| 33497-79-9 |
| n2-(d-1-carboxyethyl)taurine |
| SCHEMBL3713939 |
| n-(2-sulfoethyl)alanine |
| Q27101919 |
| DTXSID60955123 |
| (2r)-2-[(2-sulfoethyl)amino]propanoic acid |
Research Excerpts
Bioavailability
| Excerpt | Reference | Relevance |
|---|---|---|
| " In conclusion, oral ingested tauropine may be poorly absorbed by the gastrointestinal tract and transported into the blood." | ( Bioavailability of Tauropine After Oral Ingestion in Mouse. Hamano, Y; Ito, T; Maruyama, C; Murakami, S; Nguyen, KH; Schaffer, SW, 2022) | 1.34 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Drug Classes (3)
| Class | Description |
|---|---|
| D-alanine derivative | A non-proteinogenic amino acid derivative resulting from reaction of D-alanine at the amino group or the carboxy group, or from the replacement of any hydrogen of D-alanine by a heteroatom. |
| D-alpha-amino acid | |
| organosulfonic acid | An organic derivative of sulfonic acid in which the sulfo group is linked directly to carbon. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||